SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Salvatore Petta, Luca Valenti, Elisabetta Bugianesi, Giovanni Targher, Stefano Bellentani, Ferruccio Bonino, A “systems medicine” approach to the study of non-alcoholic fatty liver disease, Digestive and Liver Disease, 2016, 48, 3, 333

    CrossRef

  2. 2
    Harleen K. Dyal, Maria Aguilar, Gabriella Bartos, Edward W. Holt, Taft Bhuket, Benny Liu, Ramsey Cheung, Robert J. Wong, Diabetes Mellitus Increases Risk of Hepatocellular Carcinoma in Chronic Hepatitis C Virus Patients: A Systematic Review, Digestive Diseases and Sciences, 2016, 61, 2, 636

    CrossRef

  3. 3
    Salvatore Petta, Marcello Maida, Stefania Grimaudo, Rosaria M. Pipitone, Fabio S. Macaluso, Daniela Cabibi, Calogero Cammà, Vito Di Marco, Sandro Sferrazza, Antonio Craxì, TM6SF2 rs58542926 is not associated with steatosis and fibrosis in large cohort of patients with genotype 1 chronic hepatitis C, Liver International, 2016, 36, 2
  4. 4
    Ning Geng, Yong-Ning Xin, Harry Hua-Xiang Xia, Man Jiang, Jian Wang, Yang Liu, Li-Zhen Chen, Shi-Ying Xuan, Association of PNPLA3 I148M Variant With Chronic Viral Hepatitis, Autoimmune Liver Diseases and Outcomes of Liver Transplantation, Hepatitis Monthly, 2015, 15, 4

    CrossRef

  5. 5
    Minghao Ha, Wei Xia, Dongxu Tang, Jianqiu Wu, Liping Sun, Wenjuan Shen, Zhongming Huang, Xiaolan Chen, Wenyan Shan, Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients, Obesity Research & Clinical Practice, 2015,

    CrossRef

  6. 6
    Raluca Pais, Pascal Lebray, Geraldine Rousseau, Frédéric Charlotte, Ghizlaine Esselma, Eric Savier, Dominique Thabut, Marika Rudler, Daniel Eyraud, Corinne Vezinet, Jean-Michel Siksik, Jean-Christophe Vaillant, Laurent Hannoun, Thierry Poynard, Vlad Ratziu, Nonalcoholic Fatty Liver Disease Increases the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Associated Cirrhosis Awaiting Liver Transplants, Clinical Gastroenterology and Hepatology, 2015, 13, 5, 992

    CrossRef

  7. 7
    Garam Kim, Jin Young Kim, Hong Seok Choi, Peptidyl–Prolyl <i>cis</i>/<i>trans</i> Isomerase NIMA-Interacting 1 as a Therapeutic Target in Hepatocellular Carcinoma, Biological & Pharmaceutical Bulletin, 2015, 38, 7, 975

    CrossRef

  8. 8
    Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Shusuke Kitabatake, Takanori Ito, Risk factors of hepatocellular carcinoma development in non-cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection, Journal of Gastroenterology and Hepatology, 2015, 30, 7
  9. 9
    Fabio Salvatore Macaluso, Marcello Maida, Calogero Cammà, Daniela Cabibi, Nicola Alessi, Giuseppe Cabibbo, Vito Di Marco, Antonio Craxì, Salvatore Petta, Body Mass Index and Liver Stiffness Affect Accuracy of Ultrasonography in Detecting Steatosis in Patients With Chronic Hepatitis C Virus Genotype 1 Infection, Clinical Gastroenterology and Hepatology, 2014, 12, 5, 878

    CrossRef

  10. 10
    Hironori Tsuzura, Takuya Genda, Shunsuke Sato, Ayato Murata, Yoshio Kanemitsu, Yutaka Narita, Sachiko Ishikawa, Tetsu Kikuchi, Masashi Mori, Katsuharu Hirano, Katsuyori Iijima, Ryo Wada, Takafumi Ichida, Expression of Aldo-Keto Reductase Family 1 Member B10 in the Early Stages of Human Hepatocarcinogenesis, International Journal of Molecular Sciences, 2014, 15, 4, 6556

    CrossRef

  11. 11
    Francesco Negro, Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases, Journal of Hepatology, 2014, 61, 1, S69

    CrossRef

  12. 12
    Jean-Charles Nault, Pierre Nahon, Genetic predisposition to hepatocellular carcinoma in alcoholic cirrhosis: The NCAN-PNPLA3-lipid connection?, Journal of Hepatology, 2014, 61, 5, 971

    CrossRef

  13. 13
    Álvaro Mena, José D Pedreira, Ángeles Castro, Soledad López, Pilar Vázquez, Eva Poveda, Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers, Journal of Gastroenterology and Hepatology, 2014, 29, 1
  14. 14
    Jinah Choi, Nicole L.B. Corder, Bhargav Koduru, Yiyan Wang, Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma, Free Radical Biology and Medicine, 2014, 72, 267

    CrossRef

  15. 15
    Matthew M. Yeh, Elizabeth M. Brunt, Pathological Features of Fatty Liver Disease, Gastroenterology, 2014, 147, 4, 754

    CrossRef

  16. 16
    Nicolas Goossens, Francesco Negro, The Impact of Obesity and Metabolic Syndrome on Chronic Hepatitis C, Clinics in Liver Disease, 2014, 18, 1, 147

    CrossRef

  17. 17
    Scott A. Read, Mark W. Douglas, Virus induced inflammation and cancer development, Cancer Letters, 2014, 345, 2, 174

    CrossRef

  18. 18
    Hidenori Toyoda, Takashi Kumada, Seiki Kiriyama, Makoto Tanikawa, Yasuhiro Hisanaga, Akira Kanamori, Toshifumi Tada, Shusuke Kitabatake, Yoshiki Murakami, Association between hepatic steatosis and hepatic expression of genes involved in innate immunity in patients with chronic hepatitis C, Cytokine, 2013, 63, 2, 145

    CrossRef

  19. 19
    N. Brau, Evaluation of the Hepatitis C Virus-Infected Patient: The Initial Encounter, Clinical Infectious Diseases, 2013, 56, 6, 853

    CrossRef

  20. 20
    S. Petta, A. Handberg, G. Marchesini, C. Cammà, V. Di Marco, D. Cabibi, F. S. Macaluso, A. Craxì, High sCD36 plasma level is associated with steatosis and its severity in patients with genotype 1 chronic hepatitis C, Journal of Viral Hepatitis, 2013, 20, 3
  21. 21
    Alessandra Mangia, Maria Ripoli, Insulin resistance, steatosis and hepatitis C virus, Hepatology International, 2013, 7, S2, 782

    CrossRef

  22. 22
    M. F. Bassendine, D. A. Sheridan, S. H. Bridge, D. J. Felmlee, R. D. G. Neely, Lipids and HCV, Seminars in Immunopathology, 2013, 35, 1, 87

    CrossRef

  23. 23
    Hidenori Toyoda, Takashi Kumada, Toshifumi Tada, Lower incidence of hepatocellular carcinoma in patients with transient virologic response to peginterferon and ribavirin combination therapy: Is it really the effect of the therapy?, Journal of Hepatology, 2013, 58, 4, 838

    CrossRef

  24. 24
    Fabio Salvatore Macaluso, Marcello Maida, Maria Giovanna Minissale, Teresa Li Vigni, Simona Attardo, Emanuele Orlando, Salvatore Petta, Metabolic Factors and Chronic Hepatitis C: A Complex Interplay, BioMed Research International, 2013, 2013, 1

    CrossRef

  25. 25
    Gregory A. Michelotti, Mariana V. Machado, Anna Mae Diehl, NAFLD, NASH and liver cancer, Nature Reviews Gastroenterology & Hepatology, 2013, 10, 11, 656

    CrossRef

  26. 26
    Jacob Alexander, Michael Torbenson, Tsung-Teh Wu, Matthew M. Yeh, Non-alcoholic fatty liver disease contributes to hepatocarcinogenesis in non-cirrhotic liver: A clinical and pathological study, Journal of Gastroenterology and Hepatology, 2013, 28, 5
  27. 27
    Muqddas Tariq, Sobia Manzoor, Qazi Laeeque Ahmed, Madiha Khalid, Waseem Ashraf, NOX4 induces oxidative stress and apoptosis through upregulation of caspases 3 and 9 and downregulation of TIGAR in HCV-infected Huh-7 cells, Future Virology, 2013, 8, 7, 707

    CrossRef

  28. 28
    Olivier Rosmorduc, Relationship between hepatocellular carcinoma, metabolic syndrome and non-alcoholic fatty liver disease: Which clinical arguments?, Annales d'Endocrinologie, 2013, 74, 2, 115

    CrossRef

  29. 29
    Luigi E Adinolfi, Luciano Restivo, Aldo Marrone, The predictive value of steatosis in hepatitis C virus infection, Expert Review of Gastroenterology & Hepatology, 2013, 7, 3, 205

    CrossRef

  30. 30
    Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman, Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie, Hepatitis Monthly, 2012, 12, 1, 11

    CrossRef

  31. 31
    Sadaf Badar, Sadaf Badar, Bushra Khubaib, Bushra Khubaib, Muhammad Idrees, Muhammad Idrees, Abrar Hussain, Abrar Hussain, Zunaira Awan, Zunaira Awan, Sadia Butt, Sadia Butt, Samia Afzal, Samia Afzal, Madeeha Akram, Madeeha Akram, Zareen Fatima, Zareen Fatima, Mahwish Aftab, Mahwish Aftab, Sana Saleem, Sana Saleem, Sara Munir, Sara Munir, Bisma Rauff, Bisma Rauff, Mahrukh Naudhani, Mahrukh Naudhani, Ali Liaquat, Liaquat Ali, Muhammaad Ali, Muhammaad Ali, Irshad-ul Rehman, Irshadul Rehman, Association of Hepatitis C Virus With Insulin Resistance: Evidences From Animal Studies and Clinical Studie, Hepatitis Monthly, 2012, 12, 1, 11

    CrossRef

  32. 32
    Yi Chen, Xiaolin Wang, Jianhua Wang, Zhiping Yan, Jianjun Luo, Excess body weight and the risk of primary liver cancer: An updated meta-analysis of prospective studies, European Journal of Cancer, 2012, 48, 14, 2137

    CrossRef

  33. 33
    O. Rosmorduc, L. Fartoux, HCC and NASH: How strong is the clinical demonstration?, Clinics and Research in Hepatology and Gastroenterology, 2012, 36, 3, 202

    CrossRef

  34. 34
    Baila Samreen, Saba Khaliq, Usman Ali Ashfaq, Mahwish Khan, Nadeem Afzal, Muhammad Aiman Shahzad, Sabeen Riaz, Shah Jahan, Hepatitis C virus entry: Role of host and viral factors, Infection, Genetics and Evolution, 2012, 12, 8, 1699

    CrossRef

  35. 35
    György Baffy, Elizabeth M. Brunt, Stephen H. Caldwell, Hepatocellular carcinoma in non-alcoholic fatty liver disease: An emerging menace, Journal of Hepatology, 2012, 56, 6, 1384

    CrossRef

  36. 36
    Hidenori Toyoda, Takashi Kumada, Incidence of hepatocellular carcinoma and response to interferon therapy in HCV-infected patients: effect of factors associated with the therapeutic response and incidence of HCC, Liver International, 2012, 32, 6
  37. 37
    Salvatore Petta, Insulin resistance and diabetes mellitus in patients with chronic hepatitis C: Spectators or actors?, Digestive and Liver Disease, 2012, 44, 5, 359

    CrossRef

  38. 38
    Dominique Salmon, Firouzé Bani-Sadr, Marc-Arthur Loko, Hind Stitou, Anne Gervais, Jacques Durant, Eric Rosenthal, Yann Quertainmont, Karl Barange, Daniel Vittecoq, Michka Shoai-Tehrani, Muriel Alvarez, Maria Winnock, Jean Claude Trinchet, François Dabis, Philippe Sogni, Insulin resistance is associated with a higher risk of hepatocellular carcinoma in cirrhotic HIV/HCV-co-infected patients: Results from ANRS CO13 HEPAVIH, Journal of Hepatology, 2012, 56, 4, 862

    CrossRef

  39. 39
    K. Tanaka, I. Tsuji, A. Tamakoshi, K. Matsuo, H. Ito, K. Wakai, C. Nagata, T. Mizoue, S. Sasazuki, M. Inoue, S. Tsugane, S. Tsugane, M. Inoue, S. Sasazuki, M. Iwasaki, T. Otani, N. Sawada, T. Shimazu, I. Tsuji, Y. Tsubono, Y. Nishino, A. Tamakoshi, K. Matsuo, H. Ito, K. Wakai, C. Nagata, T. Mizoue, K. Tanaka, Obesity and Liver Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiologic Evidence Among the Japanese Population, Japanese Journal of Clinical Oncology, 2012, 42, 3, 212

    CrossRef

  40. 40
    Kymberly D. Watt, Reducing the load: The evolution and management of obesity and nonalcoholic steatohepatitis before liver transplantation, Liver Transplantation, 2012, 18, S2
  41. 41
    Zachary D. Goodman, Luigi M. Terracciano, Aileen Wee, MacSween's Pathology of the Liver, 2012,

    CrossRef

  42. 42
    G. Nkontchou, M. Ziol, M. Aout, M. Lhabadie, Y. Baazia, A. Mahmoudi, D. Roulot, N. Ganne-Carrie, V. Grando-Lemaire, J.-C. Trinchet, E. Gordien, E. Vicaut, I. Baghad, M. Beaugrand, HCV genotype 3 is associated with a higher hepatocellular carcinoma incidence in patients with ongoing viral C cirrhosis, Journal of Viral Hepatitis, 2011, 18, 10
  43. 43
    Mei-chin Mong, Che-yi Chao, Mei-chin Yin, Histidine and carnosine alleviated hepatic steatosis in mice consumed high saturated fat diet, European Journal of Pharmacology, 2011, 653, 1-3, 82

    CrossRef

  44. 44
    R. Anaparthy, J. A. Talwalkar, M. Yin, L. R. Roberts, J. L. Fidler, R. L. Ehman, Liver stiffness measurement by magnetic resonance elastography is not associated with developing hepatocellular carcinoma in subjects with compensated cirrhosis, Alimentary Pharmacology & Therapeutics, 2011, 34, 1
  45. 45
    Jonathan Goldwasser, Pazit Y. Cohen, Wenyu Lin, Danny Kitsberg, Patrick Balaguer, Stephen J. Polyak, Raymond T. Chung, Martin L. Yarmush, Yaakov Nahmias, Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism, Journal of Hepatology, 2011, 55, 5, 963

    CrossRef

  46. 46
    Luca Valenti, MariaGrazia Rumi, Enrico Galmozzi, Alessio Aghemo, Benedetta Del Menico, Stella De Nicola, Paola Dongiovanni, Marco Maggioni, Anna Ludovica Fracanzani, Raffaela Rametta, Massimo Colombo, Silvia Fargion, Patatin-Like phospholipase domain-containing 3 I148M polymorphism, steatosis, and liver damage in chronic hepatitis C, Hepatology, 2011, 53, 3
  47. 47
    Edmondo Falleti, Carlo Fabris, Sara Cmet, Annarosa Cussigh, Davide Bitetto, Elisabetta Fontanini, Ezio Fornasiere, Sara Bignulin, Elisa Fumolo, Eleonora Bignulin, Mario Pirisi, Pierluigi Toniutto, PNPLA3 rs738409C/G polymorphism in cirrhosis: relationship with the aetiology of liver disease and hepatocellular carcinoma occurrence, Liver International, 2011, 31, 8
  48. 48
    Hirokazu Takahashi, Toshihiko Mizuta, Yuichiro Eguchi, Yasunori Kawaguchi, Takuya Kuwashiro, Satoshi Oeda, Hiroshi Isoda, Noriko Oza, Shinji Iwane, Kenichi Izumi, Keizou Anzai, Iwata Ozaki, Kazuma Fujimoto, Post-challenge hyperglycemia is a significant risk factor for the development of hepatocellular carcinoma in patients with chronic hepatitis C, Journal of Gastroenterology, 2011, 46, 6, 790

    CrossRef

  49. 49
    Jian-Min Wu, Nicholas J. Skill, Mary A. Maluccio, Evidence of aberrant lipid metabolism in hepatitis C and hepatocellular carcinoma, HPB, 2010, 12, 9
  50. 50
    Masayuki Kurosaki, Takanori Hosokawa, Kotaro Matsunaga, Itsuko Hirayama, Tomohiro Tanaka, Mitsuaki Sato, Yutaka Yasui, Nobuharu Tamaki, Ken Ueda, Kaoru Tsuchiya, Teiji Kuzuya, Hiroyuki Nakanishi, June Itakura, Yuka Takahashi, Yasuhiro Asahina, Nobuyuki Enomoto, Namiki Izumi, Hepatic steatosis in chronic hepatitis C is a significant risk factor for developing hepatocellular carcinoma independent of age, sex, obesity, fibrosis stage and response to interferon therapy, Hepatology Research, 2010, 40, 9
  51. 51
    Mariana Verdelho Machado, António Gouveia Oliveira, Helena Cortez-Pinto, Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: A meta-analysis of the risk factors, Hepatology, 2010, 52, 1
  52. 52
    Mahwish Khan, Shah Jahan, Saba Khaliq, Bushra Ijaz, Waqar Ahmad, Baila Samreen, Sajida Hassan, Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis, Archives of Virology, 2010, 155, 11, 1735

    CrossRef

  53. 53
    Marianne Ziol, Jean–Charles Nault, Mounir Aout, Nathalie Barget, Maryline Tepper, Antoine Martin, Jean–Claude Trinchet, Nathalie Ganne–Carrié, Eric Vicaut, Michel Beaugrand, Gisele N'Kontchou, Intermediate Hepatobiliary Cells Predict an Increased Risk of Hepatocarcinogenesis in Patients With Hepatitis C Virus-Related Cirrhosis, Gastroenterology, 2010, 139, 1, 335

    CrossRef

  54. 54
    M. Sakamoto, K. Effendi, Y. Masugi, Molecular Diagnosis of Multistage Hepatocarcinogenesis, Japanese Journal of Clinical Oncology, 2010, 40, 9, 891

    CrossRef

  55. 55
    B. Kronenberger, S. Zeuzem, J. Bojunga, NASH und Hepatitis C, Der Gastroenterologe, 2010, 5, 2, 116

    CrossRef

  56. 56
    Abby B. Siegel, Shuang Wang, Judith S. Jacobson, Dawn L. Hershman, Emerson A. Lim, Jeanette Yu, Lauren Ferrante, Kalpana M. Devaraj, Helen Remotti, Shannon Scrudato, Karim Halazun, Jean Emond, Lorna Dove, Robert S. Brown, Alfred I. Neugut, Obesity and Microvascular Invasion in Hepatocellular Carcinoma, Cancer Investigation, 2010, 28, 10, 1063

    CrossRef

  57. 57
    P. Loria, L.E. Adinolfi, S. Bellentani, E. Bugianesi, A. Grieco, S. Fargion, A. Gasbarrini, C. Loguercio, A. Lonardo, G. Marchesini, F. Marra, M. Persico, D. Prati, G. Svegliati- Baroni, Practice guidelines for the diagnosis and management of nonalcoholic fatty liver disease, Digestive and Liver Disease, 2010, 42, 4, 272

    CrossRef

  58. 58
    Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo, Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2010, 8, 11, 924

    CrossRef

  59. 59
    Timothy J. S. Cross, Mohammed M. Rashid, Philip A. Berry, Phillip M. Harrison, The importance of steatosis in chronic hepatitis C infection and its management: A review, Hepatology Research, 2010, 40, 3
  60. 60
    W-L Tsai, R T Chung, Viral hepatocarcinogenesis, Oncogene, 2010, 29, 16, 2309

    CrossRef

  61. 61
    Hengli Tang, Henry Grisé, Cellular and molecular biology of HCV infection and hepatitis, Clinical Science, 2009, 117, 2, 49

    CrossRef

  62. 62
    Anna S. Lok, James E. Everhart, Raymond T. Chung, Hae-Young Kim, Gregory T. Everson, John C. Hoefs, Joel K. Greenson, Richard K. Sterling, Karen L. Lindsay, William M. Lee, Adrian M. Di Bisceglie, Herbert L. Bonkovsky, Marc G. Ghany, Chihiro Morishima, Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial, Hepatology, 2009, 49, 6
  63. 63
    J. Fung, C.-L. Lai, M.-F. Yuen, Hepatitis B and C virus-related carcinogenesis, Clinical Microbiology and Infection, 2009, 15, 11
  64. 64
    Sophie Clément, Stéphanie Pascarella, Francesco Negro, Hepatitis C Virus Infection: Molecular Pathways to Steatosis, Insulin Resistance and Oxidative Stress, Viruses, 2009, 1, 2, 126

    CrossRef

  65. 65
    Kazuya OGAWA, Takayuki HISHIKI, Yuko SHIMIZU, Kenji FUNAMI, Kazuo SUGIYAMA, Yusuke MIYANARI, Kunitada SHIMOTOHNO, Hepatitis C virus utilizes lipid droplet for production of infectious virus, Proceedings of the Japan Academy, Series B, 2009, 85, 7, 217

    CrossRef

  66. 66
    F. Negro, S. Clément, Impact of obesity, steatosis and insulin resistance on progression and response to therapy of hepatitis C, Journal of Viral Hepatitis, 2009, 16, 10
  67. 67
    Anna S. Lok, Leonard B. Seeff, Timothy R. Morgan, Adrian M. di Bisceglie, Richard K. Sterling, Teresa M. Curto, Gregory T. Everson, Karen L. Lindsay, William M. Lee, Herbert L. Bonkovsky, Jules L. Dienstag, Marc G. Ghany, Chihiro Morishima, Zachary D. Goodman, Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease, Gastroenterology, 2009, 136, 1, 138

    CrossRef

  68. 68
    Calogero Cammà, Salvatore Petta, Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future, Journal of Hepatology, 2009, 50, 4, 648

    CrossRef

  69. 69
    Abby B. Siegel, Andrew X. Zhu, Metabolic syndrome and hepatocellular carcinoma, Cancer, 2009, 115, 24
  70. 70
    Silvia Mirandola, Christoph H. Österreicher, Moira Marcolongo, Christian Datz, Elmar Aigner, Anne Schlabrakowski, Stefano Realdon, Martina Gerotto, Alfredo Alberti, Felix Stickel, Microsomal triglyceride transfer protein polymorphism (−493G/T) is associated with hepatic steatosis in patients with chronic hepatitis C, Liver International, 2009, 29, 4
  71. 71
    Shunhei Yamashina, Nobuhiro Sato, Kazuyoshi Kon, Kenichi Ikejima, Sumio Watanabe, Role of mitochondria in liver pathophysiology, Drug Discovery Today: Disease Mechanisms, 2009, 6, 1-4, e25

    CrossRef

  72. 72
    Stephen Caldwell, Sang H. Park, The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology, Journal of Gastroenterology, 2009, 44, S19, 96

    CrossRef

  73. 73
    Vicência M.R. de Lima, Claudia P.M.S. Oliveira, Venancio A.F. Alves, Maria Cristina Chammas, Ellen Pierre Oliveira, José Tadeu Stefano, Evandro Sobroza de Mello, Giovanni Guido Cerri, Flair José Carrilho, Stephen H. Caldwell, A rodent model of NASH with cirrhosis, oval cell proliferation and hepatocellular carcinoma, Journal of Hepatology, 2008, 49, 6, 1055

    CrossRef

  74. 74
    Chuhan Chung, Jennifer A. Doll, Arijeet K. Gattu, Christine Shugrue, Mona Cornwell, Philip Fitchev, Susan E. Crawford, Anti-angiogenic pigment epithelium-derived factor regulates hepatocyte triglyceride content through adipose triglyceride lipase (ATGL), Journal of Hepatology, 2008, 48, 3, 471

    CrossRef

  75. 75
    Zhisheng Liu, Weidong Ma, Huikai Li, Qiang Li, Clinicopathological and prognostic features of primary clear cell carcinoma of the liver, Hepatology Research, 2008, 38, 3
  76. 76
    Wojciech Blonski, K. Rajender Reddy, Hepatitis C Virus Infection and Hepatocellular Carcinoma, Clinics in Liver Disease, 2008, 12, 3, 661

    CrossRef

  77. 77
    Muhammad Y. Sheikh, Jinah Choi, Ishtiaq Qadri, Jacob E. Friedman, Arun J. Sanyal, Hepatitis C virus infection: Molecular pathways to metabolic syndrome, Hepatology, 2008, 47, 6
  78. 78
    Manuel Romero-Gómez, Pathogenesis and natural course of hepatic steatosis and insulin resistance in patients with hepatitis C, Current Hepatitis Reports, 2008, 7, 3, 113

    CrossRef

  79. 79
    J. J. BLONSKY, S. A. HARRISON, Review article: nonalcoholic fatty liver disease and hepatitis C virus – partners in crime, Alimentary Pharmacology & Therapeutics, 2008, 27, 10
  80. 80
    Aldona Kasprzak, Agnieszka Adamek, Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis, Hepatology Research, 2008, 38, 1
  81. 81
    Muhammad Y. Sheikh, Steatosis in hepatitis C: Mechanisms and basic concepts, Current Hepatitis Reports, 2008, 7, 4, 152

    CrossRef

  82. 82
    Dorry L. Segev, Stephen M. Sozio, Eun Ji Shin, Susanna M. Nazarian, Hari Nathan, Paul J. Thuluvath, Robert A. Montgomery, Andrew M. Cameron, Warren R. Maley, Steroid avoidance in liver transplantation: Meta-analysis and meta-regression of randomized trials, Liver Transplantation, 2008, 14, 4
  83. 83
    Kazuo Notsumata, Shunji Tomita, Taku Sanada, Shotaro Kosaka, Daishu Toya, Nobuyosi Tanaka, Yoshiko Sudo, You Zen, The effect of hepatic steatosis on Peginterferon alfa-2b and Ribavirin combination therapy for chronic hepatitis C, Kanzo, 2008, 49, 5, 183

    CrossRef